MedTrace Logo

Developing and Testing the Opioid Rapid Response System

NCT04589676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2022-02-07

No results posted yet for this study

Summary

This Phase I SBIR will develop and demonstrate the usability/feasibility of the Opioid Rapid Response System (OSSR) in order to reduce deaths and strain on emergency response systems from opioid overdoses.

Conditions

Interventions

BEHAVIORAL

Naloxone training

The naloxone training will teach participants about how to appropriately use naloxone in the event of an opioid overdose.

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER

  • Real Prevention, LLC

    lead INDUSTRY

Principal Investigators

  • Michael Hecht, PhD · REAL Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04589676 on ClinicalTrials.gov